(lp0
S"The Hot Stock: Alexion Pharmaceuticals Climbs 3.3% Barron's  - Apr 13, 2017 Alexion Pharmaceuticals , a drug maker focused on rare diseases, ended Thursday at the top of the list of the best performing stocks in the S&amp;P 500 index.Investors Checklist Stock: Alexion Pharmaceuticals, Inc.  - StandardOracleAlexion Pharmaceuticals, Inc. Posted losses of -0.62% in the Last Trade - Free Observer"
p1
aS'Alexion Pharmaceuticals Slid 9.9% in March -- but Why? Motley Fool - Apr 4, 2017 Shares of Alexion Pharmaceuticals , a biotech focused on rare diseases, fell 9.9% in March, according to data from S&amp;P Global Market Intelligence.Alexion Pharmaceuticals, Inc.  Stake Maintained by Philadelphia Trust Co. - BNB Daily Buy, Sell or Hold? Analysts Approach: Honeywell International Inc. (HON ... - The USA Commerce'
p2
aS"Juncture Wealth Strategies LLC Has $292000 Position in Alexion Pharmaceuticals ... The Cerbat Gem - 12 hours ago Alexion Pharmaceuticals logo Juncture Wealth Strategies LLC cut its stake in shares of Alexion Pharmaceuticals, Inc.Should You Buy, Sell, Or Hold? - Alexion Pharmaceuticals, Inc. , HRG ... - USA Commerce DailyTraders Spotlight: Alexion Pharmaceuticals, Inc.'s  - Is stories"
p3
aS'Alexion Pharma names former Baxalta chief Ludwig Hantson CEO Reuters - Mar 27, 2017 Alexion Pharmaceuticals Inc  on Monday named former Baxalta CEO Ludwig Hantson to its top job, as the rare-disease drug maker seeks to regain investor confidence following the exit of top management.Just the Facts on Alexion Pharmaceuticals, Inc.  - StockNewsJournal'
p4
aS'Alexion Pharmaceuticals Enters Oversold Territory  Nasdaq - Mar 21, 2017 In trading on Tuesday, shares of Alexion Pharmaceuticals Inc.  entered into oversold territory, hitting an RSI reading of 28.0, after changing hands as low as $117.57 per share.'
p5
aS'Commit To Buy Alexion Pharmaceuticals At $75, Earn 5.1% Using Options Nasdaq - Mar 22, 2017 Investors considering a purchase of Alexion Pharmaceuticals Inc.  stock, but cautious about paying the going market price of $119.16/share, might benefit from considering selling puts among the alternative strategies at their disposal.'
p6
aS'Alexion Pharmaceuticals Inc.  Rises 3.3% for April 14 Equities.com - Apr 14, 2017 Starting the day trading at $114.76, Alexion Pharmaceuticals Inc. reached an intraday high of $118.64 and hit intraday lows of $114.73.Alexion Pharmaceuticals, Inc.  to Post Q1 2017 Earnings of $1.04 Per ... - The Cerbat GemAlexion Pharmaceuticals  Earning Somewhat Favorable News Coverage, Study ... - Markets Daily'
p7
aS"Analysts Take: Alexion Pharmaceuticals, Inc.  Projected Earnings ... Aiken Advocate - Apr 16, 2017 Investors and analysts will be looking ahead to Alexion Pharmaceuticals, Inc. 's next earnings report which is slated to be released sometime on or around 2017-04-27 for the period ending on 2017-03-31."
p8
aS"Top Stocks of the day: Alexion Pharmaceuticals, Inc. : ALXN The News Journal - 14 hours ago With its total market value of the company's outstanding shares, the market cap of Alexion Pharmaceuticals, Inc."
p9
aS'Looking at the Levels for Alexion Pharmaceuticals, Inc.  Searcy News - 20 hours ago Alexion Pharmaceuticals, Inc.  has an EV  of 29002396. Enterprise Value measures the complete value of a specific company.'
p10
a.